Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: August 17, 2022

Drugs in MeSH Category Anti-Bacterial Agents

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065505-002	Jul 31, 2008		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Torrent	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET;ORAL	065156-002	Jan 6, 2004	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
B Braun	CEFTAZIDIME IN DEXTROSE CONTAINER	ceftazidime	INJECTABLE;INJECTION	050823-002	Jun 13, 2011		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Eugia Pharma	AZITHROMYCIN	azithromycin	INJECTABLE;INJECTION	203294-001	Jun 19, 2015	AP	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Ani Pharms	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	GRANULE;ORAL	062055-001	Approved Prior to Jan 1, 1982	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Wyeth Ayerst	UNIPEN	nafcillin sodium	FOR SOLUTION;ORAL	050199-001	Approved Prior to Jan 1, 1982		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Delcor Asset Corp	MYCOSTATIN	nystatin	PASTILLE;ORAL	050619-001	Apr 9, 1987		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Express Scripts

Harvard Business School

Johnson and Johnson

Boehringer Ingelheim

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.